Tivicay 50 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWCQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,334
Award facts
- Contract value 100% obligated
- $1,334.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,334.31 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) on May 2, 2025, with an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This delivery order represents a routine fulfillment under AmerisourceBergen's broader pharmaceutical supply agreement with the Defense Logistics Agency, which encompasses a wide range of brand-name and generic medications, vaccines, and medical supplies supporting U.S. military and veteran healthcare systems. Tivicay, an antiretroviral medication used in HIV treatment regimens, aligns with the company's established portfolio of specialty pharmaceuticals delivered through the DLA medical supply chain. The order demonstrates the company's continued role as a critical vendor in federal medical procurement, leveraging its position as a prime contractor under the DLA's pharmaceutical acquisition framework.
Quick answers
Who was awarded contract SPE2DB25FWCQ4?
SPE2DB25FWCQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FWCQ4 worth?
The government has obligated $1,334 on SPE2DB25FWCQ4.
Is contract SPE2DB25FWCQ4 an order under another contract?
Yes. SPE2DB25FWCQ4 is a delivery order under SPE2DB24D1034, an indefinite delivery contract.
Was contract SPE2DB25FWCQ4 competed?
The extent of competition for SPE2DB25FWCQ4 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award